Structure's diabetes pill misses weight-loss expectations in mid-stage trial

By Michael Erman (Reuters) -Structure Therapeutics' diabetes pill missed market expectations for weight loss in a mid-stage trial and fell short of results ...

Related Keywords

Bengaluru ,Karnataka ,India ,New York ,United States ,Raymond Stevens ,Lilly Mounjaro ,Novo Nordisk Wegovy ,Christopher Cushing ,David Risinger ,Eli Lilly ,Arun Koyyur ,Reuters ,Pfizer ,Astrazeneca ,Structure Therapeutic ,Novo Nordisk ,Roger Song ,Chief Executive Raymond Stevens ,Leerink Partners ,Carmot Therapeutics ,Structure Therapeutics ,Michael Erman ,Mariam Sunny ,